United Therapeutics Corp. (UTHR)
497.11
-6.75
(-1.34%)
USD |
NASDAQ |
Sep 11, 16:00
497.01
-0.10
(-0.02%)
After-Hours: 20:00
United Therapeutics Market Cap : 21.22B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 21.22B |
| September 10, 2026 | 21.50B |
| September 09, 2026 | 21.63B |
| September 08, 2026 | 21.25B |
| September 04, 2026 | 20.81B |
| September 03, 2026 | 20.92B |
| September 02, 2026 | 21.00B |
| September 01, 2026 | 21.88B |
| August 31, 2026 | 21.78B |
| August 28, 2026 | 22.00B |
| August 27, 2026 | 22.53B |
| August 26, 2026 | 22.05B |
| August 25, 2026 | 22.13B |
| August 24, 2026 | 21.89B |
| August 21, 2026 | 21.90B |
| August 20, 2026 | 22.23B |
| August 19, 2026 | 22.58B |
| August 18, 2026 | 22.12B |
| August 17, 2026 | 21.70B |
| August 14, 2026 | 21.33B |
| August 13, 2026 | 21.39B |
| August 12, 2026 | 21.84B |
| August 11, 2026 | 22.00B |
| August 10, 2026 | 22.60B |
| August 07, 2026 | 23.00B |
| Date | Value |
|---|---|
| August 06, 2026 | 22.74B |
| August 05, 2026 | 22.15B |
| August 04, 2026 | 22.14B |
| August 03, 2026 | 22.03B |
| July 31, 2026 | 21.82B |
| July 30, 2026 | 22.17B |
| July 29, 2026 | 22.12B |
| July 28, 2026 | 22.07B |
| July 27, 2026 | 22.26B |
| July 24, 2026 | 22.28B |
| July 23, 2026 | 22.32B |
| July 22, 2026 | 22.22B |
| July 21, 2026 | 22.59B |
| July 20, 2026 | 22.31B |
| July 17, 2026 | 22.58B |
| July 16, 2026 | 22.30B |
| July 15, 2026 | 22.42B |
| July 14, 2026 | 22.20B |
| July 13, 2026 | 22.58B |
| July 10, 2026 | 23.06B |
| July 09, 2026 | 23.29B |
| July 08, 2026 | 23.37B |
| July 07, 2026 | 23.76B |
| July 06, 2026 | 23.07B |
| July 02, 2026 | 23.44B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 5.947B |
| MannKind Corp. | 1.162B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Savara, Inc. | 1.089B |
Market Cap Related Metrics
| PE Ratio | 17.78 |
| PS Ratio | 7.391 |
| PEG Ratio | 1.940 |
| Price to Book Value | 3.315 |
| Price to Free Cash Flow | 21.51 |
| Price | 497.11 |
| Earnings Yield | 5.62% |
| PEGY Ratio | 1.940 |
| Operating PE Ratio | 16.61 |
| Normalized PE Ratio | 19.05 |